Literature DB >> 12670866

Bcl-2 constitutively suppresses p53-dependent apoptosis in colorectal cancer cells.

Ming Jiang1, Jo Milner.   

Abstract

To dissect apoptotic genes governing the survival of colorectal carcinoma cells, we employed RNAi to silence Bcl-2 and Bcl-x(L) in isogenic clones of p53+/+ and p53-/- cells, and of Bax+/- and Bax-/- cells. We identify a novel proapoptotic function of p53 that does not require activation by genotoxic agents and that appears to be constitutively suppressed by Bcl-2. Silencing of Bcl-2 induced massive p53-dependent apoptosis. The "Bcl-2/p53 axis" requires Bax and caspase 2 as essential apoptotic mediators. This newly discovered Bcl-2/p53 functional interface represents a key regulator of apoptosis which can be activated by targeting Bcl-2 in colorectal carcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670866      PMCID: PMC196025          DOI: 10.1101/gad.252603

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  20 in total

Review 1.  The Bcl2 family: regulators of the cellular life-or-death switch.

Authors:  Suzanne Cory; Jerry M Adams
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

Review 2.  Apoptosis-based therapies.

Authors:  John C Reed
Journal:  Nat Rev Drug Discov       Date:  2002-02       Impact factor: 84.694

3.  DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2.

Authors:  A Strasser; A W Harris; T Jacks; S Cory
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

4.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

5.  DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines.

Authors:  P Branch; R Hampson; P Karran
Journal:  Cancer Res       Date:  1995-06-01       Impact factor: 12.701

6.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.

Authors:  Ming Jiang; Jo Milner
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  Tumor regression by targeted gene delivery to the neovasculature.

Authors:  John D Hood; Mark Bednarski; Ricardo Frausto; Samira Guccione; Ralph A Reisfeld; Rong Xiang; David A Cheresh
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

9.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis.

Authors:  Y Ionov; M A Peinado; S Malkhosyan; D Shibata; M Perucho
Journal:  Nature       Date:  1993-06-10       Impact factor: 49.962

10.  Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome.

Authors:  Vanessa S Marsden; Liam O'Connor; Lorraine A O'Reilly; John Silke; Donald Metcalf; Paul G Ekert; David C S Huang; Francesco Cecconi; Keisuke Kuida; Kevin J Tomaselli; Sophie Roy; Don W Nicholson; David L Vaux; Philippe Bouillet; Jerry M Adams; Andreas Strasser
Journal:  Nature       Date:  2002-09-25       Impact factor: 49.962

View more
  38 in total

Review 1.  p53's believe it or not: lessons on transcription-independent death.

Authors:  Jerry E Chipuk; Douglas R Green
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

2.  BLIMP1 regulates cell growth through repression of p53 transcription.

Authors:  Junli Yan; Jianming Jiang; Ching Aeng Lim; Qiang Wu; Huck-Hui Ng; Keh-Chuang Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

3.  Mechanisms of regulatory diversity within the p53 transcriptional network.

Authors:  J M Espinosa
Journal:  Oncogene       Date:  2008-02-18       Impact factor: 9.867

4.  A role for caspase 2 and PIDD in the process of p53-mediated apoptosis.

Authors:  Nicole Baptiste-Okoh; Anthony M Barsotti; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-31       Impact factor: 11.205

5.  NSAIDs may regulate EGR-1-mediated induction of reactive oxygen species and non-steroidal anti-inflammatory drug-induced gene (NAG)-1 to initiate intrinsic pathway of apoptosis for the chemoprevention of colorectal cancer.

Authors:  Vivek Vaish; Honit Piplani; Chandan Rana; Kim Vaiphei; Sankar Nath Sanyal
Journal:  Mol Cell Biochem       Date:  2013-02-23       Impact factor: 3.396

6.  DZNep represses Bcl-2 expression and modulates apoptosis sensitivity in response to Nutlin-3a.

Authors:  Yalu Zhou; Ricardo E Perez; Lei Duan; Carl G Maki
Journal:  Cancer Biol Ther       Date:  2018-03-13       Impact factor: 4.742

7.  The expression level of the voltage-dependent anion channel controls life and death of the cell.

Authors:  Salah Abu-Hamad; Sara Sivan; Varda Shoshan-Barmatz
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Chemopreventive effects of an HDAC2-selective inhibitor on rat colon carcinogenesis and APCmin/+ mouse intestinal tumorigenesis.

Authors:  Durgadevi Ravillah; Altaf Mohammed; Li Qian; Misty Brewer; Yuting Zhang; Laura Biddick; Vernon E Steele; Chinthalapally V Rao
Journal:  J Pharmacol Exp Ther       Date:  2013-11-11       Impact factor: 4.030

9.  Mitochondrial control of cell death induced by hyperosmotic stress.

Authors:  Alfredo Criollo; Lorenzo Galluzzi; M Chiara Maiuri; Ezgi Tasdemir; Sergio Lavandero; Guido Kroemer
Journal:  Apoptosis       Date:  2007-01       Impact factor: 4.677

10.  RNAi and cancer: Implications and applications.

Authors:  Maen Abdelrahim; Stephen Safe; Cheryl Baker; Ala Abudayyeh
Journal:  J RNAi Gene Silencing       Date:  2006-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.